APCCC 2024: The Importance of Bone Protection
APCCC 2024, prostate cancer, importance of bone protection in prostate cancer treatment, zoledronic acid decrease the risk of fracture-related hospitalizations in high-risk M1 mHSPC, Fracture-related hospitalizations in de novo advanced or metastatic hormone-sensitive prostate cancer.